Evidence map›Paper›PMID 36001022›Full record

ArticleClinical orthopaedics and related research2022

A Novel Nanostructured Surface on Titanium Implants Increases Osseointegration in a Sheep Model.

Claire F Jones, Ryan D Quarrington, Helen Tsangari, Yolandi Starczak, Adnan Mulaibrahimovic, Anouck L S Burzava, Chris Christou, Alex J Barker, James Morel, Richard Bright and 4 more

Open access · greenAbstract read
In one paragraph

Article in Clinical orthopaedics and related research, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
2.4field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

14 authors at 3 institutions in 1 country.

Claire F JonesCentre for Orthopaedic and Trauma Research, Adelaide Medical School, The University of Adelaide, Adelaide, Australia.ORCID 0000-0002-0995-1182
Ryan D QuarringtonCentre for Orthopaedic and Trauma Research, Adelaide Medical School, The University of Adelaide, Adelaide, Australia.ORCID 0000-0002-0633-2482
Helen TsangariHealth and Biomedical Innovation, Clinical and Health Sciences, University of South Australia, Adelaide, Australia.ORCID 0000-0001-5675-1098
Yolandi StarczakCentre for Orthopaedic and Trauma Research, Adelaide Medical School, The University of Adelaide, Adelaide, Australia.ORCID 0000-0001-6066-8713
Adnan MulaibrahimovicCentre for Orthopaedic and Trauma Research, Adelaide Medical School, The University of Adelaide, Adelaide, Australia.
Anouck L S BurzavaSTEM, University of South Australia, Adelaide, Australia.ORCID 0000-0002-3486-2210
Chris ChristouPreclinical, Imaging and Research Laboratories, South Australian Health and Medical Research Institute, Adelaide, Australia.ORCID 0000-0003-3231-0356
Alex J BarkerHealth and Biomedical Innovation, Clinical and Health Sciences, University of South Australia, Adelaide, Australia.ORCID 0000-0002-5614-4113
James MorelCorin Australia, Pymble, Australia.
Richard BrightSTEM, University of South Australia, Adelaide, Australia.ORCID 0000-0003-1988-0725
Dan BarkerCorin Australia, Pymble, Australia.
Toby BrownCorin Australia, Pymble, Australia.
Krasimir VasilevSTEM, University of South Australia, Adelaide, Australia.ORCID 0000-0003-3534-4754
Paul H AndersonHealth and Biomedical Innovation, Clinical and Health Sciences, University of South Australia, Adelaide, Australia.ORCID 0000-0002-8685-3252
University of South Australia · AUThe University of Adelaide · AUSouth Australian Health and Medical Research Institute · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundA nanostructured titanium surface that promotes antimicrobial activity and osseointegration would provide the opportunity to create medical implants that can prevent orthopaedic infection and improve bone integration. Although nanostructured surfaces can exhibit antimicrobial activity, it is not known whether these surfaces are safe and conducive to osseointegration. QUESTIONS/PURPOSES: Using a sheep animal model, we sought to determine whether the bony integration of medical-grade, titanium, porous-coated implants with a unique nanostructured surface modification (alkaline heat treatment [AHT]) previously shown to kill bacteria was better than that for a clinically accepted control surface of porous-coated titanium covered with hydroxyapatite (PCHA) after 12 weeks in vivo. The null hypothesis was that there would be no difference between implants with respect to the primary outcomes: interfacial shear strength and percent intersection surface (the percentage of implant surface with bone contact, as defined by a micro-CT protocol), and the secondary outcomes: stiffness, peak load, energy to failure, and micro-CT (bone volume/total volume [BV/TV], trabecular thickness [Tb.Th], and trabecular number [Tb.N]) and histomorphometric (bone-implant contact [BIC]) parameters.

methodsImplants of each material (alkaline heat-treated and hydroxyapatite-coated titanium) were surgically inserted into femoral and tibial metaphyseal cancellous bone (16 per implant type; interference fit) and in tibial cortices at three diaphyseal locations (24 per implant type; line-to-line fit) in eight skeletally mature sheep. At 12 weeks postoperatively, bones were excised to assess osseointegration of AHT and PCHA implants via biomechanical push-through tests, micro-CT, and histomorphometry. Bone composition and remodeling patterns in adult sheep are similar to that of humans, and this model enables comparison of implants with ex vivo outcomes that are not permissible with humans. Comparisons of primary and secondary outcomes were undertaken with linear mixed-effects models that were developed for the cortical and cancellous groups separately and that included a random effect of animals, covariates to adjust for preoperative bodyweight, and implant location (left/right limb, femoral/tibial cancellous, cortical diaphyseal region, and medial/lateral cortex) as appropriate. Significance was set at an alpha of 0.05.

resultsThe estimated marginal mean interfacial shear strength for cancellous bone, adjusted for covariates, was 1.6 MPa greater for AHT implants (9.3 MPa) than for PCHA implants (7.7 MPa) (95% CI 0.5 to 2.8; p = 0.006). Similarly, the estimated marginal mean interfacial shear strength for cortical bone, adjusted for covariates, was 6.6 MPa greater for AHT implants (25.5 MPa) than for PCHA implants (18.9 MPa) (95% CI 5.0 to 8.1; p < 0.001). No difference in the implant-bone percent intersection surface was detected for cancellous sites (cancellous AHT 55.1% and PCHA 58.7%; adjusted difference of estimated marginal mean -3.6% [95% CI -8.1% to 0.9%]; p = 0.11). In cortical bone, the estimated marginal mean percent intersection surface at the medial site, adjusted for covariates, was 11.8% higher for AHT implants (58.1%) than for PCHA (46.2% [95% CI 7.1% to 16.6%]; p < 0.001) and was not different at the lateral site (AHT 75.8% and PCHA 74.9%; adjusted difference of estimated marginal mean 0.9% [95% CI -3.8% to 5.7%]; p = 0.70).

conclusionThese data suggest there is stronger integration of bone on the AHT surface than on the PCHA surface at 12 weeks postimplantation in this sheep model. CLINICAL RELEVANCE: Given that the AHT implants formed a more robust interface with cortical and cancellous bone than the PCHA implants, a clinical noninferiority study using hip stems with identical geometries can now be performed to compare the same surfaces used in this study. The results of this preclinical study provide an ethical baseline to proceed with such a clinical study given the potential of the alkaline heat-treated surface to reduce periprosthetic joint infection and enhance implant osseointegration.

Indexed as

Anti-Infective AgentsOsseointegrationAnimalsDurapatiteHumansProstheses and ImplantsSheepSurface PropertiesTitaniumAnti-Infective AgentsDurapatiteTitanium

Identifiers

PMID36001022
PMCPMC10476811
OpenAlexW4292937918

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.